Global Arterial Stent Market Size By Type (Coronary Stents, Peripheral Stents), By Application (Iliac Artery, Carotid Artery), By Region, And Segment Forecasts, 2023 to 2032

lobal Arterial Stent Market Report Description

The Global Arterial Stent Market was valued at USD 11.6 billion in 2023 and is projected to reach USD 19.4 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2023–2031).

The market growth is driven by the rising prevalence of cardiovascular diseases (CVDs), an aging population, and technological advancements in stent design, including drug-eluting stents (DES), bioresorbable stents, and next-generation metallic stents. Increasing healthcare expenditure, lifestyle changes leading to a higher incidence of coronary artery disease, and favorable reimbursement policies are further propelling the market demand globally.

Drivers

1. Rising Cardiovascular Disease Burden

The global increase in coronary artery disease cases, driven by sedentary lifestyles, obesity, and diabetes, is significantly boosting the need for arterial stenting procedures. According to WHO, CVDs account for nearly 18 million deaths annually, making arterial stents a critical life-saving intervention.

2. Advancements in Stent Technology

The introduction of drug-eluting stents (DES) with controlled drug release and bioresorbable vascular scaffolds (BVS) has revolutionized arterial stenting. These advancements reduce restenosis rates and improve long-term patient outcomes.

3. Increasing Aging Population

The geriatric population is more prone to cardiovascular conditions, thereby increasing the demand for minimally invasive procedures like stent implantation.

Restraints

1. High Cost of Advanced Stents

Next-generation DES and bioresorbable stents are expensive, making them less accessible in low-income regions. High procedural and hospitalization costs also limit market adoption.

2. Risks Associated with Stenting

Complications such as thrombosis, restenosis, or allergic reactions to stent materials can limit patient and physician acceptance in some cases.

Opportunities

1. Growing Demand in Emerging Economies

Developing regions, particularly Asia-Pacific and Latin America, present untapped opportunities due to increasing healthcare infrastructure, rising awareness, and expanding insurance coverage.

2. Minimally Invasive Interventions

The shift toward minimally invasive cardiac interventions, coupled with robotic-assisted surgeries, is expected to enhance stent adoption and broaden the patient base.

3. Expansion of Bioresorbable Stent Market

The growing research in biodegradable stents that gradually dissolve after arterial healing is likely to open new avenues for innovation and market growth.

Market by System Type Insights

Drug-Eluting Stents (DES) dominated the market in 2023, accounting for over 60% of revenue, due to their ability to reduce restenosis rates and improve patient outcomes.

Bare-Metal Stents (BMS) still have demand in developing regions due to their lower cost.

Bioresorbable Stents (BVS) are expected to witness the fastest growth due to their long-term benefits in younger patients.

Market by End-use Insights

Hospitals & Cardiac Centers accounted for the largest share in 2023 as most stenting procedures are performed in these specialized facilities.

Ambulatory Surgical Centers (ASCs) are expected to see rapid growth, driven by a shift toward outpatient minimally invasive cardiac procedures.

Market by Regional Insights

North America held the largest market share in 2023, supported by high healthcare spending, advanced medical technologies, and the presence of key industry players.

Europe followed closely, benefiting from a high prevalence of cardiovascular conditions and favorable reimbursement frameworks.

Asia-Pacific is projected to witness the highest CAGR, driven by increasing patient awareness, improving healthcare access, and rapid economic growth in countries like China and India.

Competitive Scenario

Key players in the Global Arterial Stent Market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Biosensors International Group, B. Braun Melsungen AG, and Biotronik SE & Co. KG.

Recent Developments

2023: Abbott launched a new generation of everolimus-eluting bioresorbable stents targeting younger patients with minimal long-term complications.

2024: Medtronic introduced an AI-powered imaging system for enhanced precision in stent placement.

2025: Boston Scientific acquired a leading bioresorbable stent startup to expand its portfolio of next-gen cardiovascular solutions.

Scope of Work – Global Arterial Stent Market

Key Market Developments

Abbott introduced a next-generation polymer-free drug-eluting stent in 2024 to reduce restenosis risk.

Boston Scientific expanded its stent manufacturing facility in Asia-Pacific in 2023 to meet growing regional demand.

Medtronic partnered with AI companies in 2025 to integrate real-time imaging and predictive analytics into stent deployment.

FAQs

What is the current market size of the Global Arterial Stent Market?

The market was valued at USD 11.6 billion in 2023.

What is the major growth driver of the Global Arterial Stent Market?

The major driver is the increasing prevalence of cardiovascular diseases and technological advancements in stent design.

Which is the largest region during the forecast period in the Global Arterial Stent Market?

North America remains the largest regional market due to advanced healthcare infrastructure and high adoption rates.

Which segment accounted for the largest market share in the Global Arterial Stent Market?

Drug-Eluting Stents (DES) accounted for the largest share in 2023.

Who are the key market players in the Global Arterial Stent Market?

Key players include Medtronic, Boston Scientific, Abbott Laboratories, Terumo, and Biosensors International.

Would you like me to also create a visual one-page summary infographic for this report to make it more appealing for presentations?